David Largaespada, Ph.D., Masonic Cancer Center's associate director of basic sciences, was named an American Cancer Society Research Professor. This is the most prestigious award given by the ACS and provides flexible funding for mid-career professors who have made seminal contributions to cancer research and provide leadership in their research area. These five-year awards, with only 25 research professors funded at any time, are granted after a very competitive peer-review process.
Reuben Harris, Ph.D., and Douglas Yee, M.D., Masonic Cancer Center director and member of the Cell Signaling Program, received a V Foundation grant to study an enzyme-catalyzed mutation in breast cancer.
Two program members received grants from the Randy Shaver Cancer Research and Community Fund:
- David Largaespada, Ph.D.: "R-spondins as drivers and therapeutic targets in breast cancer"
- Timothy Starr, Ph.D.: "A model for rapidly testing multiple ovarian cancer therapeutics"
Three program members received awards from the Masonic Cancer Center Internal Grants Program:
- Anindya Bagchi, Ph.D., was one of three recipients of the American Cancer Society Institutional Grants for 2013 for his project "Role of tumor suppressor CHD5 in DNA damage repair."
- Anja Bielinsky, Ph.D., and Jakub Tolar, M.D., Ph.D., were awarded a Brainstorm grant for their project " Comparative analysis of repair and checkpoint capacities of Fanconi anemia cells."
- Jaime Modiano, V.M.D., Ph.D., was awarded a Hematologic Malignancy Innovation award for this project "A comparative assessment of the role of the alternative NFkB pathway in DLBCL."